Pages
- Adcirca®
- Adcirca® FAQ
- Aironite®
- Ambrisentan
- BiPAP / CPAP
- Bosentan
- Calcium Channel Blockers
- Coumadin®
- Digitalis
- Diuretics
- Endothelin Receptor Antagonists
- Epoprostenol for Injection
- Epoprostenol sodium
- Flolan®
- Iloprost
- Inhaled Treprostinil
- INOmax®
- Jantoven®
- Letairis®
- Marfarin®
- Nitric Oxide
- Nitrite
- Other Drugs and Treatments
- Oxygen
- Phosphodiesterase type-5 Inhibitor
- Prostacyclin
- PTE
- Remodulin®
- Revatio®
- Sildenafil Citrate
- Sitaxsentan Sodium
- Tadalafil
- Thelin®
- Tracleer®
- Tracleer® FAQ
- Transplant
- Treprostinil
- Tyvaso®
- Under FDA Review
- Veletri®
- Ventavis®
- Viagra®
- Volibris®
- Warfarin
Oxygen
Supplementary oxygen is sometimes prescribed for PH patients when a patient has hypoxemia (an inadequate amount of available oxygen in the blood) at rest or with physical activity. Patients are considered hypoxic if their oxygen saturation levels are consistently under 88%. Unless patients with PH have an underlying hypoxic lung disease their normal oxygen saturation levels are usually above 88%.
Supplementary oxygen, however, is an important addition to treating the symptoms of a PH patient with hypoxemia or under special conditions, such as when hospitalized with a respiratory infection, or at high altitudes or sometimes when traveling by air.
For information about oxygen therapy in general, see The American Association for Respiratory Care, Home Oxygen Therapy and the National Home Oxygen Patients Association
Page Reviewed/Edited: November 2010
In The News
- May 29, 2011
- Miniventilator Greatly Improves Activity Tolerance in COPD
- December 14, 2009
- Does oxygen need humidification?
- November 4, 2009
- CMS Issues Final Rule on Oxygen Maintenance for 2010

.jpg)